Multiple Cavitary Lung Lesions in ANCA-Negative Small Vessel Vasculitis: A Case Report
Keywords:
Anti-neutrophil cytoplasmic antibody-associated vasculitis, microscopic polyangiitis, antibodies, antineutrophil cytoplasmic, lung diseases, cavitary lung lesionsAbstract
Multiple cavitary lung lesions present a diagnostic challenge, with a broad differential diagnosis, including infectious, malignant, and autoimmune etiologies. ANCA-associated vasculitis (AAV), particularly in its seronegative form, is a rare yet important cause that is frequently overlooked, as pulmonary involvement is uncommon and its manifestations can closely mimic infection or malignancy. We report a case of a 30-year-old male who presented with a three-week history of dyspnea and hemoptysis, and a background of membranoproliferative glomerulonephritis confirmed by renal biopsy three months prior, consistent with pauci-immune glomerulonephritis. Chest radiography and contrast-enhanced CT revealed multiple bilateral cavitary lung lesions with air-fluid levels, micronodules, and centrilobular ground-glass opacities. Extensive infectious workup, including sputum and bronchoalveolar lavage cultures, acid-fast bacilli smear, GeneXpert, and fungal studies, was negative. Cytological examination excluded malignancy. Both p-ANCA and c-ANCA were negative. Based on the 2022 ACR/EULAR classification criteria, a diagnosis of ANCA-negative microscopic polyangiitis (MPA) was established, with a total score of +6 derived from imaging findings consistent with interstitial lung disease and histopathological evidence of pauci-immune glomerulonephritis in a prior renal biopsy. Immunosuppressive therapy with methylprednisolone and mycophenolate sodium was initiated, resulting in complete radiological resolution of all cavitary lesions within two months. This case highlights that cavitary lung lesions may represent a rare pulmonary manifestation of ANCA-negative MPA. A negative ANCA result should not exclude vasculitis when clinical suspicion is high, and tissue biopsy remains essential for definitive diagnosis in atypical presentations.References
Nunes AG, Rodrigues MC, Carneiro C, Costa AC. Pulmonary cavitary lesions: a captivating visual review. J Thorac Dis. 2025 Aug 28;17(8):6296–308.
DB Gökten, Karabağ S, Mercan R. Pulmonary and renal predictors of mortality in ANCA-associated vasculitis: a regional experience from Türkiye. Biomedicines. 2025 Jun 7;13(6):1401.
Arora H, Sivasubramanian D, Sivakumar S, Sambandam A, Avula S. Seronegative granulomatosis with polyangiitis with isolated lung lesions: a case report. Cureus. 2024 May 5;16(5):e59692.
Hellmich B, Sanchez-Alamo B, Schirmer JH, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024 Jan 2;83(1):30–47.
Chen H, Lin Z, Jian X. Diffuse pulmonary lesions caused by ANCA-associated vasculitis: a case report. Medicine (Baltimore). 2025 Aug 22;104(34):e43811.
Lakhdar S, Nassar M, Shatabdi S, Buttar C, Abrudescu A, Trandafirescu T. A cavitary lesion in a patient with antineutrophilic cytoplasmic antibody (ANCA) associated vasculitis: a case report and review of the literature. J Intensive Care Med. 2023 Jan;38(1):114–20.
Mollaeian A, Chan N, Aloor R, Iding JS, Arend LJ, Saeidabadi SHF, Haas CJ. ANCA-negative microscopic polyangiitis with diffuse alveolar hemorrhage masquerading as congestive heart failure. Autoimmun Highlights. 2021 Jan 6;12(1):1.
Fouka E, Drakopanagiotakis F, Steiropoulos P. Pathogenesis of pulmonary manifestations in ANCA-associated vasculitis and Goodpasture syndrome. Int J Mol Sci. 2024 May 12;25(10):5278.
Redondo-Rodriguez R, Mena-Vázquez N, Cabezas-Lucena AM, Manrique-Arija S, Mucientes A, Fernández-Nebro A. Systematic review and meta-analysis of worldwide incidence and prevalence of antineutrophil cytoplasmic antibody (ANCA) associated vasculitis. J Clin Med. 2022 May 4;11(9):2573.
Zhou P, Li Z, Gao L, Que C, Li H, Ma J, Wang G, Chen M. Pulmonary involvement of ANCA-associated vasculitis in adult Chinese patients. BMC Pulm Med. 2022 Jan 12;22(1):35.
Zhang T, Li L, Huang S, Starodubtseva MN, Liu J. Anti-endothelial cell antibodies in pathogenesis of vasculitis. Front Immunol. 2025 Apr 30;16:1567293.
Sun X, Li Z, Chen M. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Immunol Res. 2023 Mar;4(1):11–21.
Ambrogi E, Cavazza A, Smith ML, Graziano P. Pulmonary pathology in vasculitis. Pathologica. 2024 Apr 30;116(2):93–103.
Duong TB, Ceglar S, Reaume M, Harber P. Imaging approach to cavitary lung disease. Ann Am Thorac Soc. 2020 Mar;17(3):367–71.
Gafoor K. Cavitary lung diseases: a clinical-radiologic algorithmic approach. Chest. 2018 Jun;153(6):1443–65.
Marvisi C, Ricordi C, Catellani C, Croci S, Muratore F, Salvarani C. Biomarkers in ANCA-associated vasculitis: clinical utility, pitfalls and their role in the outcomes assessment. Front Immunol. 2025 Sep 22;16:1616837.
Brilland B, Garnier AS, Chevailler A, Jeannin P, Subra JF, Augusto JF. Complement alternative pathway in ANCA-associated vasculitis: two decades of progress and pending questions. Autoimmun Rev. 2022 Jun;21(6):103331.
Wang A, Bittar HET, Greene J. Beyond infection and malignancy: diagnostic pitfalls in pulmonary granulomatosis with polyangiitis. Cureus. 2026 Jan 9;18(1):e101192.
Alnaser A, Parperis K. Mycobacterium kansasii infection and microscopic polyangiitis: an unexpected association. Cureus. 2018 Jun 18;10(6):e2831.
Sreih AG, Cronin K, Shaw DG, Young K, Burroughs C, Kullman J, Machireddy K, McAlear CA, Merkel PA. Diagnostic delays in vasculitis and factors associated with time to diagnosis. Orphanet J Rare Dis. 2021 Apr 21;16(1):184.
Suppiah R, Robson JC, Grayson PC, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Arthritis Rheumatol. 2022 Mar;74(3):400–6.
Shi J, Shen Q, Chen XM, Du XG. Clinical characteristics and outcomes in microscopic polyangiitis patients with renal involvement: a study of 124 Chinese patients. BMC Nephrol. 2019 Sep 2;20(1):354.
Zhang Y, Ding Q, Lv C, Ying Y, Cen Z, Zhou H, et al. Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities. Clin Respir J. 2023;17(5).
Comarmond C, Crestani B, Tazi A, et al. Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature.Medicine (Baltimore). 2014 Nov;93(24):340-9.
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2024 clinical practice guideline for glomerular diseases. Kidney Int. 2024;105(4S):S1–S276.
Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021 Feb 18;384(7):599–609.
Babapoor P, Hajialilo M, Rahimi M, et al. Predictors of medication-free and long-term remission in anti-neutrophil cytoplasmic antibody-associated vasculitis: real-world evidence. Sarcoidosis Vasc Diffuse Lung Dis. 2024;41(1):e2024008
Ni A, Xu Y, Chen J, Han F. Advances in the assessment and treatment of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. J Inflamm Res. 2024 Dec 31:17:11881-900. doi: 10.2147/JIR.S494848. eCollection 2024.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Anshari Saifuddin Hasibuan, Rizqi Najla Humaira, Sukamto Koesnoe, Evy Yunihastuti, Alvina Widhani, Suzy Maria, Bramantya Wicaksana, Cleopas Martin Rumende, Pringgodigdo Nugroho

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright
The authors who publish in this journal agree to the following requirements:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)
Privacy Statement
The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.
